SARS-CoV-2 spike protein as a bacterial lipopolysaccharide delivery system in an overzealous inflammatory cascade
Journal of Molecular Cell Biology · 2023
DOI: 10.1093/jmcb/mjac058 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Molecular Cell Biology, 2023. Verfasst von Firdaus Samsudin und 8 weiteren Autor:innen. Beteiligte Einrichtung: Bioinformatics Institute (BII), Agency for Science, Technology and Research (A*STAR), Singapore 138671, Singapore. Hauptthemen laut MEDLINE: NF-kappa B, COVID-19. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: BII, Swedish Research Council, Edvard Welanders Stiftelse.
Abstract (Originalsprache)
Accumulating evidence indicates a potential role for bacterial lipopolysaccharide (LPS) in the overactivation of the immune response during SARS-CoV-2 infection. LPS is recognized by Toll-like receptor 4, mediating proinflammatory effects. We previously reported that LPS directly interacts with SARS-CoV-2 spike (S) protein and enhances proinflammatory activities. Using native gel electrophoresis and hydrogen–deuterium exchange mass spectrometry, we showed that LPS binds to multiple hydrophobic pockets spanning both the S1 and S2 subunits of the S protein. Molecular simulations validated by a microscale thermophoresis binding assay revealed that LPS binds to the S2 pocket with a lower affinity compared to S1, suggesting a role as an intermediate in LPS transfer. Congruently, nuclear factor-kappa B (NF-κB) activation in monocytic THP-1 cells is strongly boosted by S2. Using NF-κB reporter mice followed by bioimaging, a boosting effect was observed for both S1 and S2, with the former potentially facilitated by proteolysis. The Omicron S variant binds to LPS, but with reduced affinity and LPS boosting in vitro and in vivo. Taken together, the data provide a molecular mechanism by which S protein augments LPS-mediated hyperinflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Bioinformatics Institute (BII), Agency for Science, Technology and Research (A*STAR), Singapore 138671, Singapore.
- Department of Biological Sciences, National University of Singapore, Singapore 117543, Singapore.
- Division of Dermatology and Venereology, Department of Clinical Sciences, Lund University, SE-22184 Lund, Sweden.
- Life Sciences Institute, Centre for Life Sciences, National University of Singapore, Singapore 117546, Singapore.
- Department of Chemistry, The Pennsylvania State University, PA 16801, USA.
- Copenhagen Wound Healing Center, Bispebjerg Hospital, Department of Biomedical Sciences, University of Copenhagen, DK-2400 Copenhagen, Denmark.
ORCID-Profile: Ganna Petruk, Artur Schmidtchen
Förderung
- BII
- Swedish Research Council
- Edvard Welanders Stiftelse
- Stiftelsen Lars Hiertas Minne
Zitieren
APA
Samsudin, F., Raghuvamsi, P., Petruk, G., Puthia, M., Petrlova, J., MacAry, P., Anand, G. S., Bond, P. J., & Schmidtchen, A. (2023). SARS-CoV-2 spike protein as a bacterial lipopolysaccharide delivery system in an overzealous inflammatory cascade. Journal of Molecular Cell Biology. https://doi.org/10.1093/jmcb/mjac058
Vancouver
Samsudin F, Raghuvamsi P, Petruk G, Puthia M, Petrlova J, MacAry P, et al. SARS-CoV-2 spike protein as a bacterial lipopolysaccharide delivery system in an overzealous inflammatory cascade. Journal of Molecular Cell Biology. 2023. doi:10.1093/jmcb/mjac058
BibTeX
@article{Samsudin2023,
author = {Samsudin, Firdaus and Raghuvamsi, Palur and Petruk, Ganna and Puthia, Manoj and Petrlova, Jitka and MacAry, Paul and Anand, Ganesh S and Bond, Peter J and Schmidtchen, Artur},
title = {SARS-CoV-2 spike protein as a bacterial lipopolysaccharide delivery system in an overzealous inflammatory cascade},
journal = {Journal of Molecular Cell Biology},
year = {2023},
doi = {10.1093/jmcb/mjac058}
}
EUVIMED